Mergers and acquisitions reshape corporate landscapes and require careful legal navigation. From regulatory approvals through due diligence and deal closure, our practice guides businesses through the complex M&A process.
We provide integrated M&A advisory covering target identification, legal due diligence, structuring, regulatory approvals, documentation, and closing. We balance buyer interests (representing acquirers) or seller interests (representing targets) through sophisticated negotiations.
Our Services Include
Our Expertise
We navigate complex M&A transactions in regulated sectors (pharmaceuticals, financial services) where sectoral approval is required, and manage cross-border transactions involving foreign investment considerations.
Asset sales transfer specific assets and liabilities; stock sales transfer ownership. Asset sales isolate liability exposure but may involve tax implications and asset-by-asset transfer formalities.
Common approvals include Foreign Investment Promotion Board (FIPB) for foreign investments, sector regulator approvals (e.g., RBI for financial services), and CCI clearance for certain transactions.
Escrow is funds held by third party pending verification of representations. If representations are breached, escrowed funds compensate the buyer. Escrow typically lasts 12-18 months post-closing.
Earn-out links portion of purchase price to achievement of post-closing performance targets. It aligns buyer-seller interests but can create disputes regarding achievement of targets.
Non-compete prevents seller from competing with business post-sale (typically 2-5 years). Non-solicitation prevents solicitation of customers or employees. Both are enforceable if reasonable in scope and duration.
INQUIRY FORM